Navigation Links
Are you being served?
Date:5/20/2010

Demented patients are often treated nonspecifically with psychoactive medications. Neuroleptic drugs are given even when they are not specifically indicated, as Tomislav Majic and his colleagues from the Charit Hospital, Berlin, show in the current issue of Deutsches rzteblatt International (Dtsch Arztebl Int 2010; 107[18]: 320-7).

As dementia worsens, neuropsychiatric symptoms such as depression, apathy, and aggressiveness become more common. These cause suffering, not just for the patient, but also for the nursing staff and for the patient's fellow elderly home residents. In this cross-sectional study, the authors analyzed data on 304 demented patients from 18 homes for the elderly in Berlin. More than half of them were being treated with neuroleptic drugs; on the other hand, anti-dementia drugs were only rarely prescribed, despite evidence of their effectiveness in severe dementia.

Psychoactive drugs can have serious side effects that increase the risk of death. The authors recommend, therefore, that they be used with specific goals in mind, in accordance with existing guidelines. Other, complementary therapies, not necessarily pharmacological, should also be considered.


'/>"/>

Contact: Dr. Michael Rapp
michael.rapp@charite.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Free InkBGone Stain Removal Products Being Offered By StainHotline.com
2. Attain Fertility Offers 3 Steps to Protect Emotional Well-being While Trying to Get Pregnant
3. With Long-Term Exercise, Being 80 Is Just a Number
4. Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates?
5. Being obese can attract bullies
6. American Human Development Project Releases 'A Century Apart,' Revealing Alarming Disparities in Well-Being Among U.S. Racial and Ethnic Groups
7. Being Blinded By Jealousy Can Be Real
8. New Breast Cancer Book Offers Humor Filled Look at Being Thirty-Something, Single And Getting Through Diagnosis
9. New mums beat the blues and increase wellbeing with physio exercise, study reveals
10. Being Active an Hour a Day Puts Brakes on Weight Gain
11. Stop Ripping Me Off! Is the Title of a New Consumer Protection Book Being Released Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... PA (PRWEB) , ... August 03, 2015 , ... ... Africa , Infectious diseases researchers from the University of Pittsburgh School of Medicine ... rollout of HIV prevention drugs in sub-Saharan Africa. , A cooperative agreement ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, the nation’s ... offer pharmacogenetic lab testing and precision medicine solutions that can help pharmacists and ... Annually, more than 8.6 million adverse drug events are reported in the U.S. ...
(Date:8/3/2015)... ... 2015 , ... Catalent Pharma Solutions, the leading global provider ... products, today welcomed the announcement by OPKO Health that the US Food and ... treatment for chronic kidney disease (CKD) and vitamin D insufficiency, which uses Catalent’s ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Dental ... to help patients in need. Most people know that general health emergencies, such as ... a fewer amount of people know where to turn to during a dental emergency. ...
(Date:8/3/2015)... Orlando, FL (PRWEB) , ... August 03, 2015 ... ... upgrade to date of its industry-defining contract lifecycle management solution, as well as ... features designed to increase the speed and ease of contract management tasks as ...
Breaking Medicine News(10 mins):Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Novatus Unveils Milestone Software Release 2
... help lower the risk of pre-eclampsia, doctors say. ,Their ... high-risk women can reduce the risk of perinatal death ... of pre-eclampsia or who had chronic hypertension, diabetes or ... mg to 150 mg) //of aspirin were less likely ...
... reduce their risk of heart attacks, shows a new ... minimize cardiovascular disease in people with high cholesterol, and ... cholesterol levels who have other conditions that put them ... have a significantly //higher risk of heart disease. The ...
... Vitamin D could hold a clue to more effective breast ... of Dartmouth researchers in a report in the June issue ... involved the treatment of breast cancer tumors in mice, adds ... vitamin D known as EB1089 may yield some powerful anti-cancer ...
... serve as a new target for drugs designed to treat ... a homolog of a protein found in the fruit fly ... Institute for Biological Studies in La Jolla, California, and colleagues ... search to identify proteins that modulate the activity of Akt, ...
... of hot flashes in menopausal women, a drug company-funded ... the drug's effectiveness was limited. Alternative treatments to hormone ... night sweats and memory and sleep problems will be ... //hormone therapy increases women's risks of cancer, strokes and ...
... powerful endorsement to new strategic directions for child and ... reduce childhood deaths and long term disability. It also ... year. ,Last year, the number of children and adolescents ... deaths from AIDS, tuberculosis and malaria combined.// In 2000 ...
Cached Medicine News:Health News:Hope for 11 million children facing death from illnesses 2
(Date:8/3/2015)... 2015 VWR (NASDAQ: VWR ), ... announces the redesign of its global website, www.vwr.com , ... visiting the new site, guests will enjoy enhanced content on ... images.  Each country site now includes: , ... menu; and , the ability to search by discipline/industry. ...
(Date:8/3/2015)... , August 3, 2015 ... Media Group LLC, PIV757417 The following release: "Biotech ... Orphan Drug Products & Treatments for Critical-Care Patients ... Distribution time: 3 Aug 2015 12:30 GMT ... companies, military surgical research and top-tier universities for ...
(Date:8/3/2015)... , Aug. 3, 2015  Charleston Laboratories, Inc., ... its second clinical development program with a Phase ... CL-H1T contains fast-dissolving promethazine and ... as a treatment for migraine headache pain and ... "Many patients with migraine headaches also suffer from ...
Breaking Medicine Technology:VWR's New Website Redesign Provides Improved Functionality for Customers 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2
... May Include Direct Activity in the Brain , ... help reduce neurodegeneration and enhance repair of the,CNS ... from the six-month multiple,sclerosis Phase II clinical study ... was significantly lower in the,FTY720 groups compared to ...
... May 4, at 9:00 a.m.,Eastern Time to Discuss ... Inc. today announced that new data from the ... the Company's,six-month Phase 2 efficacy study of Dimebon ... patients on,all five efficacy endpoints studied. , The ...
Cached Medicine Technology:Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: